Powder: -20°C for 3 years | In solvent: -80°C for 2 years
GS87 is a highly specific inhibitor of GSK3 (glycogen synthase kinase 3) that induces extensive differentiation of AML cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 133.00 | |
2 mg | In stock | $ 198.00 | |
5 mg | In stock | $ 297.00 | |
10 mg | In stock | $ 453.00 | |
25 mg | In stock | $ 747.00 | |
50 mg | In stock | $ 1,050.00 | |
100 mg | In stock | $ 1,420.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 313.00 |
Description | GS87 is a highly specific inhibitor of GSK3 (glycogen synthase kinase 3) that induces extensive differentiation of AML cells. |
In vitro | GS87 potently inhibits growth of AML cells in mice with little effect on normal bone marrow cells. GS87 causes terminal differentiation of AML cells |
Synonyms | 4-[5-[[(3-Phenyl-1,2,4-oxadiazol-5-yl)methyl]thio]-1,3,4-oxadiazol-2-yl]pyridine |
Molecular Weight | 337.36 |
Formula | C16H11N5O2S |
CAS No. | 919936-70-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
DMSO: 25 mg/mL (74.1 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GS87 919936-70-2 PI3K/Akt/mTOR signaling Stem Cells GSK-3 GS-87 GSK3α Inhibitor 4-[5-[[(3-Phenyl-1,2,4-oxadiazol-5-yl)methyl]thio]-1,3,4-oxadiazol-2-yl]pyridine Glycogen synthase kinase 3 MAPK GS 87 inhibit Glycogen synthase kinase-3 GSK3 AML differentiation GSK3β inhibitor